2月18日，位于北京前门大街旁的廊房头条，游客在花灯下拍照。春节期间，北京前门步行街及周边商 圈各式花灯流光溢彩，吸引众多游客前来打卡拍照。中新社记者赵隽摄 中新社北京2月23日电 (记者吕少威陈杭)北京市商务局23日发布的数据显示，2026年春节假期，该局重 点监测的百货、超市、专业专卖店、餐饮和电商等业态企业实现销售额84.5亿元人民币。据手机信令和 第三方大数据，北京60个重点商圈假期客流量达5109.4万人次，同比增长5.8%。 这个假期，北京商圈年俗消费活力多点迸发。隆福寺商圈新春市集汇集京味小吃、盲盒手办、书籍文创 等多元业态。湾里·王府井WellTown打造"来湾里，过中国年"六大主题活动，打造"文旅商+沉浸式体 验"模式。三里屯太古里携手品牌打造潮流舞狮文化主题展览。首钢园推出光影秀、艺术展览、冰雪体 验等多元节庆活动。 春节假期，北京首发首秀、科技赋能焕新消费场景。蓝色港湾系列活动联动新品首发，以潮流艺术营造 春节欢庆消费氛围；朝阳合生汇推出潮玩、服装系列新品首展首发，时尚氛围与年节消费共振。2026海 淀新春科技庙会推动科技体验与消费场景深度融合。北京经济技术开发区开展北京首个自动驾驶乘车 ...

Core Insights - The China International Import Expo (CIIE) showcases innovative products across various sectors, including healthcare and automotive, with a record participation of 155 countries and over 4,108 foreign enterprises [1][2] Product Highlights - Notable medical products include the Ferghana needleless intravenous catheter, which reduces the risk of needle-stick injuries, and the 3DMax hernia repair patch, designed for quick deployment and reduced postoperative pain [2] - The Marie particle therapy system by Fosun Pharma represents a revolutionary advancement in cancer treatment, offering a cost-effective and space-saving alternative to traditional systems [2] - Tesla's Cybercab, an autonomous electric vehicle, features a streamlined design without a steering wheel or pedals, utilizing a vision processing system for self-driving capabilities [3] Market Entry and Transformation - The CIIE serves as a platform for global medical technology companies to convert exhibits into market-ready products, with BD Medical reporting that nearly 95% of their showcased products have entered the market [4] - Fosun Pharma has leveraged the CIIE to accelerate the introduction of cutting-edge technologies and innovative medical products into China [4] Investment Opportunities - The CIIE has attracted foreign exhibitors to become investors in China, with BD Medical planning to establish a new innovation center in Tianjin [5] - Tutti Pharmaceuticals, which successfully entered the Chinese market last year, is now considering building a factory in China to enhance its research and development capabilities [6]